Region: United Kingdom

Landmark Dutch appeal court decision reduces risk of third-party damages against pharma patentees

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

What’s ahead for the global IP market in 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022

The top five patent stories in Europe during 2021

New German legislation, a leap forward on the UPC and important SEP-related initiatives from the UK and the Commission were among the highlights of a busy year

23 December 2021

The biggest biopharma patent stories of the year

From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries

21 December 2021

Crucial clauses in global IP transactions and the importance of local law advice

In this Q&A, three Gowlings WLG professionals provide practical advice from a local law perspective for IP transactions in three jurisdictions: Canada, China and the United Kingdom.

15 December 2021

Major US and UK SEP/FRAND reviews will have global licensing impact

Biden administration flags revised policy statement that rolls-back on original 2019 version, while the British government begins development of post-Brexit approach

07 December 2021

Huawei knocks out two Chinese patents in global SEP dispute with IP Bridge

Exclusive data shows extent of Japanese firm’s Chinese patent holdings as it heads into a high-stakes rate-setting battle

03 December 2021

Chongqing is home to latest Chinese court asked to set global FRAND rate

The dispute between Oppo and Nokia has brought big-ticket global patent litigation to one of China’s biggest cities

10 November 2021

European plausibility uncertainties could be cleared up by new Enlarged Board of Appeal referral

The EPO is seeking clarity on a crucial question facing patentees, but not everyone is sure that a recent referral is the best vehicle

04 November 2021

Courts split on AI inventorship and patenting

The Long Read: Those hoping for clarity on whether AI programmes can be regarded as inventors for patent purposes will be disappointed by the different ways in which courts around the world have handled the issue so far. Helen Macpherson, Tanvi Shah and Avi Toltzis of Baker & McKenzie look at recent developments

20 October 2021

Unlock unlimited access to all IAM content